SL-880338

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSL-880338
Drug Alias NameSL880338-08
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor inverse agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety DisordersSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi-Synthelabo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Synthelabo
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorAnxiety DisordersSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A